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Abstract—Precision Extruding Deposition (PED) process was 
used to directly fabricate Polycaprolactone (PCL) and PCL/ 
Hydroxyapatite (HA) composite tissue scaffolds. HA powder was 
melt blended with PCL, a biodegradable polymer. Scaffolds with 
controlled pore size porosity were fabricated. The scaffold 
morphology and the mechanical properties were evaluated using 
SEM and mechanical testing. In vivo biological studies were 
conducted to investigate the cellular responses of the PCL 
scaffolds. Results and characterizations demonstrate the viability 
of the PED process as well as the good mechanical property, 
structural integrity, controlled pore size, pore interconnectivity, 
and the biological compatibility of the fabricated scaffolds.   
 
I. INTRODUCTION 
Three-dimensional scaffolds play important roles in 
scaffold guided tissue engineering because they provide 
critical functions as extra-cellular matrices onto which cells 
can attach, grow, and form new tissues. To design scaffolds 
for load bearing tissue replacement, researchers often needs to 
address multiple biological, mechanical and geometrical 
design constraint in terms of scaffold external and internal 
geometry, porosity, pore size and interconnectivity in order to 
provide the needed structural integrity, strength, transport 
property, and an ideal micro-environment for cell and tissue 
in-growth and healing [1-4]. This paper presents research 
employing a computer-aided tissue engineering approach, 
with a novel precision extruding deposition process for the 
design and fabrication of Polycaprolactone (PCL) and 
composite Polycaprolactone/ Hydroxyapatite scaffolds for 
bone tissue engineering applications. A biomimetic design 
and freeform fabrication method, and in vitro/in vivo study of 
biocompatibility, cell proliferation and new bone growth for 
PCL and PCL/HA scaffolds will be reported.    
 
Precision Extrusion Deposition  
A Precision Extruding Deposition (PED) system, developed 
at Drexel University was used for fabrication of the bone 
tissue scaffolds . The PED system employs the Solid Freeform 
Fabrication, or layered manufacturing technique. First bulk 
material is fed into a heated chamber where it is liquefied. 
Pressure from a rotating screw forces the material down the 
chamber and out through the nozzle tip. As the material exits 
the extruder, it begins to solidify forming small diameter 
filaments or “roads”. The roads are extruded to form a 2-
dimensional thin layer. The extruder is then raised on the z 
direction and another layer is constructed onto the previously 
fabricated layer. The result is a 3- dimensional structure with a 
precisely controlled internal architecture.  
 
 
Fig.1: Configuration of the PED fabrication system 
 
II. MATERIAL AND METHODS 
A. Materials 
 
Hydroxyapatite (HA, Clarkson Chromatography Products 
Inc, South Williamsport, PA), a calcium phosphate ceramic, 
has been widely investigated for bone tissue engineering 
applications because of its chemical similarity to the mineral 
constituent of natural bone. It is both mechanically strong and 
osteoconductive. However, because of its brittle characteristic 
and material properties, it is often difficult to process.  
Polycaprolactone (PCL, Sigma Aldrich Inc, Milwaukee, 
Wisconsin) in the form of pellets was used as the scaffolding 
material. PCL is a semi-crystalline aliphatic polymer that has a 
slower degradation rate than most biopolymers in its homo-
polymeric form. It has a low glass transition temperature at -
60ºC, a melting temperature at about 58ºC - 60ºC, and a high 
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 thermal stability. It has a high decomposition temperature Td 
of 350ºC. The mechanical properties of PCL (Mw = 44,000) 
with a tensile strength of 16MPa, tensile modulus of 400MPa, 
flexural modulus of 500MPa, elongation at yield of 7.0%, and 
elongation at break of 80% have been reported.  
A composite PCL/HA material would provide increased 
osteocondutivity and mechanical strength over scaffolds 
constructed of PCL alone.  
 
B. Design and Fabrication 
 
Hydroxyapatite powder, with particles ranging in size from 
20-53 microns, was melt blended with PCL, with 33% HA by 
weight.  
Cylindrical scaffolds, measuring 20mm in diameter and 
10mm in height, with 300 micron pores 65% porosity was 
fabricated.  Each layer was filled with the designed scaffold 
pattern of a 0/90 degree orientation to generate the porous 
structure.  The definition of scaffold layout pattern is shown 
in Fig. 2. 
 
Fig.2: layout pattern of the scaffold structures 
 
III. RESULTS OF CHARACTERIZATION 
A. SEM 
 
FEI/Phillips XL-30 Field Emission Environmental 
Scanning Electron Microscope (ESEM) was used to evaluate 
the micro-structural formability and internal morphologies of 
the fabricated scaffolds. The SEM images were taken by using 
a beam intensity at 20.0 keV and the Gaseous Secondary 
electron detectors at 1.3 Torr. The SEM images of scaffolds 
are shown in Fig. 3(a) (for 0°/90° deposition pattern) of 
composite PCL/HA and Fig. 3(b) (for 0°/90° deposition 
pattern) of PCL only scaffolds [9]. The good uniformity of the 
fill gaps and the depositing struts shown demonstrate the 
applicability of using the PED process to fabricate PCL 







Fig.3: SEM images of the scaffold structures 
3(a): PCL/HA composite scaffold; 3(b) PCL only scaffold [9] 
B. Biological Study 
An in vitro initial cell viability study was conducted at 
Drexel on HA/PCL composite scaffolds. Osteoblast cells 
(7F2) were seeded onto cylindrical samples with 300 micro 
pores and a poricity of 65%, and left to incubate for 4 days. A 
live/dead assay was preformed to determine the location an 
approximate number of living cells. The experiment indicated 
that the composite material was, biocompatible with positive 
cell attachment and proliferation on the entire top surface of 
the scaffold structure, as shown in Figure 2. 
 
 An in-vivo study was conducted at the Medical University 
of South Carolina to determine if cell seeded PCL scaffolds 
would induce osteogenesis. PCL scaffolds of the 350 micro 
pore size were cut to 8mm x 2.5mm and implanted 
subcutaneously into 5-week old nude mice after being seeded 
with fetal bovine osteoblast cells. At 8 weeks the implants 
were removed and characterized with H&E stain as well a 
Micro-CT analysis. The result was numerous areas of bone 
growth as seen in Figure 3. 
 
 
H&E stain of ex-plant PCL scaffolds 
@ 4x and 45x magnification  
 
 
Micro-CT showing Osteogenesis 
Fig.3: Preliminary results of on vivo study for PCL scaffold 
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Fig.2: Florescent cell culture image of the scaffold after 4 days. 
(a) at 4x (b) at 10x  
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